Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07834047Not yet recruiting
Randomised, double-blind trial in post-traumatic olfactory dysfunction (PTOD) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Clinical Smell Identification Test (CSIT) score improvement rate at 4 weeks. Planned start Sep 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07834047.